Announcement of the appointment of Corporate
Governance Officer
Date of events
2022/08/04
To which item it meets
paragraph 8
Statement
1.Type of personnel changed (please enter:
spokesperson, acting spokesperson, important
personnel (CEO, COO, CMO, CSO, etc.), financial
officer, accounting officer, corporate governance
officer, chief information security officer,research
and development officer, internal audit officer, or
designated and non-designated representatives):Corporate Governance Officer
2.Date of occurrence of the change:2022/08/04
3.Name, title, and resume of the previous position holder:N/A
4.Name, title, and resume of the new position holder:Lin Yi Wen
Accounting & Finance Deputy Director
5.Type of change (please enter: "resignation",
"position adjustment", "dismissal", "retirement",
"death" or "new replacement"):new replacement
6.Reason for the change:new replacement
7.Effective date:2022/09/01
8.Any other matters that need to be specified:N/A
Attachments
Original Link
Original Document
Permalink
Disclaimer
Arich Enterprise Co. Ltd. published this content on 04 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2022 09:36:03 UTC.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
